Evaluation of internal medicine physicians’ attitudes toward the treatment of dyslipidemia

References

• Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21;129(3):399–410.
   PubMed Web of Science ®Google Scholar
• Nichols M, Townsend N, Scarborough P, et al. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014 Nov 7;35(42):2929.
   PubMedGoogle Scholar
• Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Eur Heart J. 2016 Oct 14;37(39):2999–3058.
   PubMed Web of Science ®Google Scholar
• Stone VE, Mansourati FF, Poses RM, et al. Relation of physician specialty and HIV/AIDS experience to choice of guideline-recommended antiretroviral therapy. J Gen Intern Med. 2001 June;16(6):360–368.
   PubMed Web of Science ®Google Scholar
• Keil U. Coronary artery disease: the role of lipids, hypertension and smoking. Basic Res Cardiol. 2000;95(Suppl 1):I52–8.
   PubMedGoogle Scholar
• Koren MJ, Hunninghake DB, Investigators A. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study. J Am Coll Cardiol. 2004 Nov 2;44(9):1772–1779.
   PubMed Web of Science ®Google Scholar
• Feldman T, Koren M, Insull W Jr., et al. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain national cholesterol education program adult treatment panel III low-density lipoprotein cholesterol goals. Am J Cardiol. 2004 June 15;93(12):1481–1486.
   PubMed Web of Science ®Google Scholar
• Ding R, Ye P, Zhao S, et al. Effect of physician characteristics and knowledge on the quality of dyslipidemia management and LDL-C target goal achievement in China: subgroup analysis of the dyslipidemia international study. J Glob Health. 2017 Dec;7(2):020702.
   PubMed Web of Science ®Google Scholar
• Sager HB, Linsel-Nitschke P, Mayer B, et al. Physicians’ perception of guideline-recommended low-density lipoprotein target values: characteristics of misclassified patients. Eur Heart J. 2010 May;31(10):1266–1273.
   PubMed Web of Science ®Google Scholar
• Catapano AL, Graham I, De Backer G, et al. 2016 ESC/EAS guidelines for the management of dyslipidaemias. Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):115.
   PubMedGoogle Scholar
• Finkel JB, Duffy D. 2013 ACC/AHA cholesterol treatment guideline: paradigm shifts in managing atherosclerotic cardiovascular disease risk. Trends Cardiovasc Med. 2015 May;25(4):340–347.
   PubMed Web of Science ®Google Scholar
• Vashitz G, Meyer J, Parmet Y, et al. Physician adherence to the dyslipidemia guidelines is as challenging an issue as patient adherence. Fam Pract. 2011 Oct;28(5):524–531.
   PubMed Web of Science ®Google Scholar
• Alburikan KA, Asiri RM, Alhammad AM, et al. Utilization and adherence to guideline-recommended lipid-lowering therapy at an academic medical center. Ann Saudi Med. 2017 July-Aug;37(4):276–281.
   PubMed Web of Science ®Google Scholar
• Ng C, Chung P, Toderika Y, et al. Evaluation of adherence to current guidelines for treatment of hyperlipidemia in adults in an outpatient setting. Am J Health Syst Pharm. 2016 Dec 1;73(23 Supplement 6):S133–S140.
   PubMed Web of Science ®Google Scholar
• Hobbs FD, Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey. Fam Pract. 2002 Dec;19(6):596–604.
   PubMed Web of Science ®Google Scholar
• Banegas JR, Lopez-Garcia E, Dallongeville J, et al. Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J. 2011 Sep;32(17):2143–2152.
   PubMed Web of Science ®Google Scholar
• Setia S, Fung SS, Waters DD. Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore. Vasc Health Risk Manag. 2015;11:303–310.
   PubMed Web of Science ®Google Scholar
• Zaitoun MF, Iflaifel MH, Almulhim LA, et al. Awareness of physicians and clinical pharmacists about ACC/AHA guidelines for dyslipidemia management: a cross-sectional study. J Pharm Bioallied Sci. 2019 Apr-June;11(2):181–186.
   PubMed Web of Science ®Google Scholar
• Doroodchi H, Abdolrasulnia M, Foster JA, et al. Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events. BMC Fam Pract. 2008 July 8;9:42.
   PubMed Web of Science ®Google Scholar
• Wander GS, Jadhav UM, Chemburkar A, et al. Lipid management in India: a nationwide, cross-sectional physician survey. Lipids Health Dis. 2017 July 3;16(1):130.
   PubMedGoogle Scholar
• Eaton CB, Galliher JM, McBride PE, et al. Family physician’s knowledge, beliefs, and self-reported practice patterns regarding hyperlipidemia: a National Research Network (NRN) survey. J Am Board Fam Med. 2006 Jan-Feb;19(1):46–53.
   PubMed Web of Science ®Google Scholar
• Campione JR, Sleath B, Biddle AK, et al. The influence of physicians’ guideline compliance on patients’ statin adherence: a retrospective cohort study. Am J Geriatr Pharmacother. 2005 Dec;3(4):229–239.
   PubMedGoogle Scholar
• Nielsen SF, Nordestgaard BG. Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study. Eur Heart J. 2016 Mar 14;37(11):908–916.
   PubMed Web of Science ®Google Scholar
• Yarzebski J, Bujor CF, Goldberg RJ, et al. A community-wide survey of physician practices and attitudes toward cholesterol management in patients with recent acute myocardial infarction. Arch Intern Med. 2002 Apr 8;162(7):797–804.
   PubMedGoogle Scholar